“Cost-Efficient and Accurate Risk Assessment Instruments in Type 2 Diabetics With Greatest Risk for Cardiovascular Disease”. 2026. Cardiology and Cardiovascular Medicine 10 (2): 71-78. https://fortunejournals.org/ojs/index.php/ccm/article/view/16687.